Internal Medicine, Hematology & Oncology · Duluth, MN
NPI
1952391716
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1001 E Superior St, Ste. L101
Duluth, MN, 55802
Phone (218) 249-3081
Groups this clinician bills Medicare through
Medicare paid, 2024
$33K
532 services
Medicare patients, 2024
165
Average age 73
Drug cost, 2024
$2.7M
1,536 prescriptions
Company payments, 2025
$43.25
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Homam Alkaied was code 99214 (office e&m - established), 175 times for 74 patients. In total Homam Alkaied billed 532 services in 11 codes, and Medicare paid $33K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-05-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 175 | 74 | $67.20 | $12K |
| 99213 Office E&M - Established | Facility | 131 | 85 | $44.04 | $5,769 |
| 99215 Office E&M - Established | Facility | 88 | 42 | $108.54 | $9,552 |
| 99204 Office E&M - New | Facility | 19 | 19 | $103.28 | $1,962 |
By year: 2022 $45K for 649 services; 2023 $33K for 483 services; 2024 $33K for 532 services.
Medicare prescription drug claims, 2024
In 2024, the drug Homam Alkaied prescribed most often to Medicare patients was Anastrozole, with 160 prescriptions and refills. In total Homam Alkaied wrote 1,536 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 160 | 326 | 41 | $3,031 |
| Potassium Chloride Generic | 86 | 142 | 31 | $1,875 |
| Tamoxifen Citrate Generic | 66 | 134 | 16 | $1,561 |
| Prochlorperazine Maleate Generic | 64 | 64 | 51 | $1,212 |
| Acyclovir Generic | 55 | 97 | 14 | $986 |
| Dexamethasone Generic | 51 | 74 | 31 | $953 |
| Xarelto Rivaroxaban | 49 | 105 | 12 | $55K |
| Xtandi Enzalutamide | 42 | 48 | Under 11 | $515K |
| Gabapentin Generic | 39 | 52 | Under 11 | $389 |
| Eliquis Apixaban | 39 | 68 | 13 | $37K |
| Oxycodone Hcl Generic | 38 | 38 | 13 | $528 |
| Exemestane Generic | 34 | 64 | Under 11 | $3,193 |
| Allopurinol Generic | 34 | 56 | 13 | $350 |
| Furosemide Generic | 33 | 58 | 11 | $144 |
| Prednisone Generic | 32 | 38 | 13 | $249 |
Brand drugs: 313 claims; generic drugs: 1,223 claims; opioid claims: 76.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Homam Alkaied $43.25 ($43.25 in general payments such as food, travel and fees) from 3 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $43.25.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 1 | $43.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.